Industry Research Reports

Home > Reports > Chemical & Material > Valacyclovir API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Valacyclovir API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Chemical & Material

Published Date: 2026-06-16

Pages: 135 Pages

Report ld: 6784569

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Valacyclovir API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.

The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Valacyclovir API cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Valaciclovir(CAS：124832-26-4), also spelled valacyclovir, is an antiviral medication used to treat outbreaks of herpes simplex or herpes zoster (shingles).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report provides a comprehensive view of the global market for Valacyclovir API, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Valacyclovir API market size, estimations, and forecasts are presented in terms of sales volume (Kg) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Valacyclovir API.

MARKET SEGMENTATION

By Company

Mylan
NEWEDGE Overseas
Aurore Life Sciences
Arch Pharmalabs
SMS Pharmaceuticals
Exemed PharmaceuticalsFDAWHO-GMP
Aurobindo Pharma LimitedFDAEDQMWHO-GMP
Piramal Pharma Solutions
Rajasthan Antibiotics
Vital Laboratories Private Limited

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Above 98 %
Above 99 %

Segment by Application

Tablets
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.

Chapter 2: Provides a detailed analysis of the Valacyclovir API manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Valacyclovir API sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Valacyclovir API sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.

Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Valacyclovir API Product Introduction

1.2 Global Valacyclovir API Market Size Forecast

1.2.1 Global Valacyclovir API Sales Value (2021–2032)

1.2.2 Global Valacyclovir API Sales Volume (2021–2032)

1.2.3 Global Valacyclovir API Sales Price (2021–2032)

1.3 Valacyclovir API Market Trends & Drivers

1.3.1 Valacyclovir API Industry Trends

1.3.2 Valacyclovir API Market Drivers & Opportunities

1.3.3 Valacyclovir API Market Challenges

1.3.4 Valacyclovir API Market Restraints

1.3.5 Impact of U.S. Tariffs

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Valacyclovir API Players Revenue Ranking (2025)

2.2 Global Valacyclovir API Revenue by Company (2021–2026)

2.3 Global Valacyclovir API Sales Volume Ranking of Players (2025)

2.4 Global Valacyclovir API Sales Volume by Company (2021–2026)

2.5 Global Valacyclovir API Average Price by Company (2021–2026)

2.6 Key Manufacturers Valacyclovir API Manufacturing Base and Headquarters

2.7 Key Manufacturers Valacyclovir API Product Offerings

2.8 Key Manufacturers Start of Mass Production of Valacyclovir API

2.9 Valacyclovir API Market Competitive Analysis

2.9.1 Valacyclovir API Market Concentration Rate (2021–2026)

2.9.2 Global 5 and 10 Largest Manufacturers by Valacyclovir API Revenue in 2025

2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Valacyclovir API revenue, 2025

2.10 Mergers & Acquisitions and Expansion

3 Segmentation Valacyclovir API Market Classification

3.1 Introduction by Type

3.1.1 Above 98 %

3.1.2 Above 99 %

3.1.3 Global Valacyclovir API Sales Value by Type

3.1.3.1 Global Valacyclovir API Sales Value by Type (2021 vs 2025 vs 2032)

3.1.3.2 Global Valacyclovir API Sales Value, by Type (2021–2032)

3.1.3.3 Global Valacyclovir API Sales Value, by Type (%), 2021–2032

3.1.4 Global Valacyclovir API Sales Volume by Type

3.1.4.1 Global Valacyclovir API Sales Volume by Type (2021 vs 2025 vs 2032)

3.1.4.2 Global Valacyclovir API Sales Volume, by Type (2021–2032)

3.1.4.3 Global Valacyclovir API Sales Volume, by Type (%), 2021–2032

3.1.5 Global Valacyclovir API Average Price by Type (2021–2032)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Tablets

4.1.2 Others

4.2 Global Valacyclovir API Sales Value by Application

4.2.1 Global Valacyclovir API Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Valacyclovir API Sales Value, by Application (2021–2032)

4.2.3 Global Valacyclovir API Sales Value, by Application (%), 2021–2032

4.3 Global Valacyclovir API Sales Volume by Application

4.3.1 Global Valacyclovir API Sales Volume by Application (2021 vs 2025 vs 2032)

4.3.2 Global Valacyclovir API Sales Volume, by Application (2021–2032)

4.3.3 Global Valacyclovir API Sales Volume, by Application (%), 2021–2032

4.4 Global Valacyclovir API Average Price by Application (2021–2032)

5 Segmentation by Region

5.1 Global Valacyclovir API Sales Value by Region

5.1.1 Global Valacyclovir API Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Valacyclovir API Sales Value by Region (2021–2026)

5.1.3 Global Valacyclovir API Sales Value by Region (2027–2032)

5.1.4 Global Valacyclovir API Sales Value by Region (%), 2021–2032

5.2 Global Valacyclovir API Sales Volume by Region

5.2.1 Global Valacyclovir API Sales Volume by Region: 2021 vs 2025 vs 2032

5.2.2 Global Valacyclovir API Sales Volume by Region (2021–2026)

5.2.3 Global Valacyclovir API Sales Volume by Region (2027–2032)

5.2.4 Global Valacyclovir API Sales Volume by Region (%), 2021–2032

5.3 Global Valacyclovir API Average Price by Region (2021–2032)

5.4 North America

5.4.1 North America Valacyclovir API Sales Value, 2021–2032

5.4.2 North America Valacyclovir API Sales Value by Country (%), 2025 vs 2032

5.5 Europe

5.5.1 Europe Valacyclovir API Sales Value, 2021–2032

5.5.2 Europe Valacyclovir API Sales Value by Country (%), 2025 vs 2032

5.6 Asia Pacific

5.6.1 Asia Pacific Valacyclovir API Sales Value, 2021–2032

5.6.2 Asia Pacific Valacyclovir API Sales Value by Region (%), 2025 vs 2032

5.7 South America

5.7.1 South America Valacyclovir API Sales Value, 2021–2032

5.7.2 South America Valacyclovir API Sales Value by Country (%), 2025 vs 2032

5.8 Middle East & Africa

5.8.1 Middle East & Africa Valacyclovir API Sales Value, 2021–2032

5.8.2 Middle East & Africa Valacyclovir API Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Valacyclovir API Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Valacyclovir API Sales Value and Sales Volume

6.2.1 Key Countries/Regions Valacyclovir API Sales Value, 2021–2032

6.2.2 Key Countries/Regions Valacyclovir API Sales Volume, 2021–2032

6.3 United States

6.3.1 United States Valacyclovir API Sales Value, 2021–2032

6.3.2 United States Valacyclovir API Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Valacyclovir API Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Valacyclovir API Sales Value, 2021–2032

6.4.2 Europe Valacyclovir API Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Valacyclovir API Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Valacyclovir API Sales Value, 2021–2032

6.5.2 China Valacyclovir API Sales Value by Type (%), 2025 vs 2032

6.5.3 China Valacyclovir API Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Valacyclovir API Sales Value, 2021–2032

6.6.2 Japan Valacyclovir API Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Valacyclovir API Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Valacyclovir API Sales Value, 2021–2032

6.7.2 South Korea Valacyclovir API Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Valacyclovir API Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Valacyclovir API Sales Value, 2021–2032

6.8.2 Southeast Asia Valacyclovir API Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Valacyclovir API Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Valacyclovir API Sales Value, 2021–2032

6.9.2 India Valacyclovir API Sales Value by Type (%), 2025 vs 2032

6.9.3 India Valacyclovir API Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 Mylan

7.1.1 Mylan Company Information

7.1.2 Mylan Introduction and Business Overview

7.1.3 Mylan Valacyclovir API Sales, Revenue, Price and Gross Margin (2021–2026)

7.1.4 Mylan Valacyclovir API Product Offerings

7.1.5 Mylan Recent Developments

7.2 NEWEDGE Overseas

7.2.1 NEWEDGE Overseas Company Information

7.2.2 NEWEDGE Overseas Introduction and Business Overview

7.2.3 NEWEDGE Overseas Valacyclovir API Sales, Revenue, Price and Gross Margin (2021–2026)

7.2.4 NEWEDGE Overseas Valacyclovir API Product Offerings

7.2.5 NEWEDGE Overseas Recent Developments

7.3 Aurore Life Sciences

7.3.1 Aurore Life Sciences Company Information

7.3.2 Aurore Life Sciences Introduction and Business Overview

7.3.3 Aurore Life Sciences Valacyclovir API Sales, Revenue, Price and Gross Margin (2021–2026)

7.3.4 Aurore Life Sciences Valacyclovir API Product Offerings

7.3.5 Aurore Life Sciences Recent Developments

7.4 Arch Pharmalabs

7.4.1 Arch Pharmalabs Company Information

7.4.2 Arch Pharmalabs Introduction and Business Overview

7.4.3 Arch Pharmalabs Valacyclovir API Sales, Revenue, Price and Gross Margin (2021–2026)

7.4.4 Arch Pharmalabs Valacyclovir API Product Offerings

7.4.5 Arch Pharmalabs Recent Developments

7.5 SMS Pharmaceuticals

7.5.1 SMS Pharmaceuticals Company Information

7.5.2 SMS Pharmaceuticals Introduction and Business Overview

7.5.3 SMS Pharmaceuticals Valacyclovir API Sales, Revenue, Price and Gross Margin (2021–2026)

7.5.4 SMS Pharmaceuticals Valacyclovir API Product Offerings

7.5.5 SMS Pharmaceuticals Recent Developments

7.6 Exemed PharmaceuticalsFDAWHO-GMP

7.6.1 Exemed PharmaceuticalsFDAWHO-GMP Company Information

7.6.2 Exemed PharmaceuticalsFDAWHO-GMP Introduction and Business Overview

7.6.3 Exemed PharmaceuticalsFDAWHO-GMP Valacyclovir API Sales, Revenue, Price and Gross Margin (2021–2026)

7.6.4 Exemed PharmaceuticalsFDAWHO-GMP Valacyclovir API Product Offerings

7.6.5 Exemed PharmaceuticalsFDAWHO-GMP Recent Developments

7.7 Aurobindo Pharma LimitedFDAEDQMWHO-GMP

7.7.1 Aurobindo Pharma LimitedFDAEDQMWHO-GMP Company Information

7.7.2 Aurobindo Pharma LimitedFDAEDQMWHO-GMP Introduction and Business Overview

7.7.3 Aurobindo Pharma LimitedFDAEDQMWHO-GMP Valacyclovir API Sales, Revenue, Price and Gross Margin (2021–2026)

7.7.4 Aurobindo Pharma LimitedFDAEDQMWHO-GMP Valacyclovir API Product Offerings

7.7.5 Aurobindo Pharma LimitedFDAEDQMWHO-GMP Recent Developments

7.8 Piramal Pharma Solutions

7.8.1 Piramal Pharma Solutions Company Information

7.8.2 Piramal Pharma Solutions Introduction and Business Overview

7.8.3 Piramal Pharma Solutions Valacyclovir API Sales, Revenue, Price and Gross Margin (2021–2026)

7.8.4 Piramal Pharma Solutions Valacyclovir API Product Offerings

7.8.5 Piramal Pharma Solutions Recent Developments

7.9 Rajasthan Antibiotics

7.9.1 Rajasthan Antibiotics Company Information

7.9.2 Rajasthan Antibiotics Introduction and Business Overview

7.9.3 Rajasthan Antibiotics Valacyclovir API Sales, Revenue, Price and Gross Margin (2021–2026)

7.9.4 Rajasthan Antibiotics Valacyclovir API Product Offerings

7.9.5 Rajasthan Antibiotics Recent Developments

7.10 Vital Laboratories Private Limited

7.10.1 Vital Laboratories Private Limited Company Information

7.10.2 Vital Laboratories Private Limited Introduction and Business Overview

7.10.3 Vital Laboratories Private Limited Valacyclovir API Sales, Revenue, Price and Gross Margin (2021–2026)

7.10.4 Vital Laboratories Private Limited Valacyclovir API Product Offerings

7.10.5 Vital Laboratories Private Limited Recent Developments

8 Industry Chain Analysis

8.1 Valacyclovir API Industrial Chain

8.2 Valacyclovir API Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customer Analysis)

8.5 Sales Model and Sales Channelss

8.5.1 Valacyclovir API Sales Model

8.5.2 Sales Channels

8.5.3 Valacyclovir API Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Valacyclovir API Market Trends

Table 2. Valacyclovir API Market Drivers & Opportunities

Table 3. Valacyclovir API Market Challenges

Table 4. Valacyclovir API Market Restraints

Table 5. Global Valacyclovir API Revenue by Company (US$ Million), 2021–2026

Table 6. Global Valacyclovir API Revenue Market Share by Company (2021–2026)

Table 7. Global Valacyclovir API Sales Volume by Company (Kg), 2021–2026

Table 8. Global Valacyclovir API Sales Volume Market Share by Company (2021–2026)

Table 9. Global Market Valacyclovir API Price by Company (US$/Kg), 2021–2026

Table 10. Key Manufacturers Valacyclovir API Manufacturing Base and Headquarters

Table 11. Key Manufacturers Valacyclovir API Product Type

Table 12. Key Manufacturers Start of Mass Production of Valacyclovir API

Table 13. Global Valacyclovir API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Valacyclovir API revenue, 2025

Table 15. Mergers & Acquisitions and Expansion Plans

Table 16. Global Valacyclovir API Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 17. Global Valacyclovir API Sales Value by Type (US$ Million), 2021–2026

Table 18. Global Valacyclovir API Sales Value by Type (US$ Million), 2027–2032

Table 19. Global Valacyclovir API Sales Market Share in Value by Type (2021–2026)

Table 20. Global Valacyclovir API Sales Market Share in Value by Type (2027–2032)

Table 21. Global Valacyclovir API Sales Volume by Type: 2021 vs 2025 vs 2032 (Kg)

Table 22. Global Valacyclovir API Sales Volume by Type (Kg), 2021–2026

Table 23. Global Valacyclovir API Sales Volume by Type (Kg), 2027–2032

Table 24. Global Valacyclovir API Sales Market Share in Volume by Type (2021–2026)

Table 25. Global Valacyclovir API Sales Market Share in Volume by Type (2027–2032)

Table 26. Global Valacyclovir API Price by Type (US$/Kg), 2021–2026

Table 27. Global Valacyclovir API Price by Type (US$/Kg), 2027–2032

Table 28. Global Valacyclovir API Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 29. Global Valacyclovir API Sales Value by Application (US$ Million), 2021–2026

Table 30. Global Valacyclovir API Sales Value by Application (US$ Million), 2027–2032

Table 31. Global Valacyclovir API Sales Market Share in Value by Application (2021–2026)

Table 32. Global Valacyclovir API Sales Market Share in Value by Application (2027–2032)

Table 33. Global Valacyclovir API Sales Volume by Application: 2021 vs 2025 vs 2032 (Kg)

Table 34. Global Valacyclovir API Sales Volume by Application (Kg), 2021–2026

Table 35. Global Valacyclovir API Sales Volume by Application (Kg), 2027–2032

Table 36. Global Valacyclovir API Sales Market Share in Volume by Application (2021–2026)

Table 37. Global Valacyclovir API Sales Market Share in Volume by Application (2027–2032)

Table 38. Global Valacyclovir API Price by Application (US$/Kg), 2021–2026

Table 39. Global Valacyclovir API Price by Application (US$/Kg), 2027–2032

Table 40. Global Valacyclovir API Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 41. Global Valacyclovir API Sales Value by Region (US$ Million), 2021–2026

Table 42. Global Valacyclovir API Sales Value by Region (US$ Million), 2027–2032

Table 43. Global Valacyclovir API Sales Value by Region (%), 2021–2026

Table 44. Global Valacyclovir API Sales Value by Region (%), 2027–2032

Table 45. Global Valacyclovir API Sales Volume by Region (Kg): 2021 vs 2025 vs 2032

Table 46. Global Valacyclovir API Sales Volume by Region (Kg), 2021–2026

Table 47. Global Valacyclovir API Sales Volume by Region (Kg), 2027–2032

Table 48. Global Valacyclovir API Sales Volume by Region (%), 2021–2026

Table 49. Global Valacyclovir API Sales Volume by Region (%), 2027–2032

Table 50. Global Valacyclovir API Average Price by Region (US$/Kg), 2021–2026

Table 51. Global Valacyclovir API Average Price by Region (US$/Kg), 2027–2032

Table 52. Key Countries/Regions Valacyclovir API Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 53. Key Countries/Regions Valacyclovir API Sales Value, (US$ Million), 2021–2026

Table 54. Key Countries/Regions Valacyclovir API Sales Value, (US$ Million), 2027–2032

Table 55. Key Countries/Regions Valacyclovir API Sales Volume, (Kg), 2021–2026

Table 56. Key Countries/Regions Valacyclovir API Sales Volume, (Kg), 2027–2032

Table 57. Mylan Company Information

Table 58. Mylan Introduction and Business Overview

Table 59. Mylan Valacyclovir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 60. Mylan Valacyclovir API Product Offerings

Table 61. Mylan Recent Developments

Table 62. NEWEDGE Overseas Company Information

Table 63. NEWEDGE Overseas Introduction and Business Overview

Table 64. NEWEDGE Overseas Valacyclovir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 65. NEWEDGE Overseas Valacyclovir API Product Offerings

Table 66. NEWEDGE Overseas Recent Developments

Table 67. Aurore Life Sciences Company Information

Table 68. Aurore Life Sciences Introduction and Business Overview

Table 69. Aurore Life Sciences Valacyclovir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 70. Aurore Life Sciences Valacyclovir API Product Offerings

Table 71. Aurore Life Sciences Recent Developments

Table 72. Arch Pharmalabs Company Information

Table 73. Arch Pharmalabs Introduction and Business Overview

Table 74. Arch Pharmalabs Valacyclovir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 75. Arch Pharmalabs Valacyclovir API Product Offerings

Table 76. Arch Pharmalabs Recent Developments

Table 77. SMS Pharmaceuticals Company Information

Table 78. SMS Pharmaceuticals Introduction and Business Overview

Table 79. SMS Pharmaceuticals Valacyclovir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 80. SMS Pharmaceuticals Valacyclovir API Product Offerings

Table 81. SMS Pharmaceuticals Recent Developments

Table 82. Exemed PharmaceuticalsFDAWHO-GMP Company Information

Table 83. Exemed PharmaceuticalsFDAWHO-GMP Introduction and Business Overview

Table 84. Exemed PharmaceuticalsFDAWHO-GMP Valacyclovir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 85. Exemed PharmaceuticalsFDAWHO-GMP Valacyclovir API Product Offerings

Table 86. Exemed PharmaceuticalsFDAWHO-GMP Recent Developments

Table 87. Aurobindo Pharma LimitedFDAEDQMWHO-GMP Company Information

Table 88. Aurobindo Pharma LimitedFDAEDQMWHO-GMP Introduction and Business Overview

Table 89. Aurobindo Pharma LimitedFDAEDQMWHO-GMP Valacyclovir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 90. Aurobindo Pharma LimitedFDAEDQMWHO-GMP Valacyclovir API Product Offerings

Table 91. Aurobindo Pharma LimitedFDAEDQMWHO-GMP Recent Developments

Table 92. Piramal Pharma Solutions Company Information

Table 93. Piramal Pharma Solutions Introduction and Business Overview

Table 94. Piramal Pharma Solutions Valacyclovir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 95. Piramal Pharma Solutions Valacyclovir API Product Offerings

Table 96. Piramal Pharma Solutions Recent Developments

Table 97. Rajasthan Antibiotics Company Information

Table 98. Rajasthan Antibiotics Introduction and Business Overview

Table 99. Rajasthan Antibiotics Valacyclovir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 100. Rajasthan Antibiotics Valacyclovir API Product Offerings

Table 101. Rajasthan Antibiotics Recent Developments

Table 102. Vital Laboratories Private Limited Company Information

Table 103. Vital Laboratories Private Limited Introduction and Business Overview

Table 104. Vital Laboratories Private Limited Valacyclovir API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 105. Vital Laboratories Private Limited Valacyclovir API Product Offerings

Table 106. Vital Laboratories Private Limited Recent Developments

Table 107. Key Raw Materials Lists

Table 108. Key Suppliers of Raw Materials Lists

Table 109. Valacyclovir API Downstream Customers

Table 110. Valacyclovir API Distributors List

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Valacyclovir API Product Picture

Figure 2. Global Valacyclovir API Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Valacyclovir API Sales Value (US$ Million), 2021–2032

Figure 4. Global Valacyclovir API Sales Volume (Kg), 2021–2032

Figure 5. Global Valacyclovir API Sales Price (US$/Kg), 2021–2032

Figure 6. Valacyclovir API Report Years Considered

Figure 7. Global Valacyclovir API Players Revenue Ranking (US$ Million), 2025

Figure 8. Global Valacyclovir API Sales Volume Ranking of Players (Kg), 2025

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Valacyclovir API Revenue in 2025

Figure 10. Valacyclovir API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 11. Above 98 % Picture

Figure 12. Above 99 % Picture

Figure 13. Global Valacyclovir API Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Valacyclovir API Sales Value Market Share by Type, 2025 & 2032

Figure 15. Global Valacyclovir API Sales Volume by Type (Kg), 2021 vs 2025 vs 2032

Figure 16. Global Valacyclovir API Sales Volume Market Share by Type, 2025 & 2032

Figure 17. Global Valacyclovir API Price by Type (US$/Kg), 2021–2032

Figure 18. Product Picture of Tablets

Figure 19. Product Picture of Others

Figure 20. Global Valacyclovir API Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 21. Global Valacyclovir API Sales Value Market Share by Application, 2025 & 2032

Figure 22. Global Valacyclovir API Sales Volume by Application (Kg), 2021 vs 2025 vs 2032

Figure 23. Global Valacyclovir API Sales Volume Market Share by Application, 2025 & 2032

Figure 24. Global Valacyclovir API Price by Application (US$/Kg), 2021–2032

Figure 25. North America Valacyclovir API Sales Value (US$ Million), 2021–2032

Figure 26. North America Valacyclovir API Sales Value by Country (%), 2025 vs 2032

Figure 27. Europe Valacyclovir API Sales Value (US$ Million), 2021–2032

Figure 28. Europe Valacyclovir API Sales Value by Country (%), 2025 vs 2032

Figure 29. Asia Pacific Valacyclovir API Sales Value (US$ Million), 2021–2032

Figure 30. Asia Pacific Valacyclovir API Sales Value by Region (%), 2025 vs 2032

Figure 31. South America Valacyclovir API Sales Value (US$ Million), 2021–2032

Figure 32. South America Valacyclovir API Sales Value by Country (%), 2025 vs 2032

Figure 33. Middle East & Africa Valacyclovir API Sales Value (US$ Million), 2021–2032

Figure 34. Middle East & Africa Valacyclovir API Sales Value by Country (%), 2025 vs 2032

Figure 35. Key Countries/Regions Valacyclovir API Sales Value (%), 2021–2032

Figure 36. Key Countries/Regions Valacyclovir API Sales Volume (%), 2021–2032

Figure 37. United States Valacyclovir API Sales Value (US$ Million), 2021–2032

Figure 38. United States Valacyclovir API Sales Value by Type (%), 2025 vs 2032

Figure 39. United States Valacyclovir API Sales Value by Application (%), 2025 vs 2032

Figure 40. Europe Valacyclovir API Sales Value (US$ Million), 2021–2032

Figure 41. Europe Valacyclovir API Sales Value by Type (%), 2025 vs 2032

Figure 42. Europe Valacyclovir API Sales Value by Application (%), 2025 vs 2032

Figure 43. China Valacyclovir API Sales Value (US$ Million), 2021–2032

Figure 44. China Valacyclovir API Sales Value by Type (%), 2025 vs 2032

Figure 45. China Valacyclovir API Sales Value by Application (%), 2025 vs 2032

Figure 46. Japan Valacyclovir API Sales Value (US$ Million), 2021–2032

Figure 47. Japan Valacyclovir API Sales Value by Type (%), 2025 vs 2032

Figure 48. Japan Valacyclovir API Sales Value by Application (%), 2025 vs 2032

Figure 49. South Korea Valacyclovir API Sales Value (US$ Million), 2021–2032

Figure 50. South Korea Valacyclovir API Sales Value by Type (%), 2025 vs 2032

Figure 51. South Korea Valacyclovir API Sales Value by Application (%), 2025 vs 2032

Figure 52. Southeast Asia Valacyclovir API Sales Value (US$ Million), 2021–2032

Figure 53. Southeast Asia Valacyclovir API Sales Value by Type (%), 2025 vs 2032

Figure 54. Southeast Asia Valacyclovir API Sales Value by Application (%), 2025 vs 2032

Figure 55. India Valacyclovir API Sales Value (US$ Million), 2021–2032

Figure 56. India Valacyclovir API Sales Value by Type (%), 2025 vs 2032

Figure 57. India Valacyclovir API Sales Value by Application (%), 2025 vs 2032

Figure 58. Valacyclovir API Industrial Chain

Figure 59. Valacyclovir API Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Valacyclovir API market? zhanKai

The top companies in the global Valacyclovir API market are Mylan、NEWEDGE Overseas、Aurore Life Sciences.

Related Reports

Global Valacyclovir API Market Research Report 2026
The global Valacyclovir API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-18
Pages: 126
USD 2900.00
(Single User License)
Global Valacyclovir API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Valacyclovir API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-09
Pages: 78
USD 4250.00
(Single User License)
Global Valacyclovir API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Valacyclovir API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-09
Pages: 132
USD 4900.00
(Single User License)
Valacyclovir API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Valacyclovir API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 96
USD 3950.00
(Single User License)
Global Valacyclovir API Market Research Report 2025
The global market for Valacyclovir API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-16
Pages: 92
USD 2900.00
(Single User License)
Global Valacyclovir API Market Research Report 2024
Valaciclovir(CAS：124832-26-4), also spelled valacyclovir, is an antiviral medication used to treat outbreaks of herpes simplex or herpes zoster (shingles).
Published Date: 2024-02-07
Pages: 102
USD 2900.00
(Single User License)

Global Valacyclovir API Market Research Report 2026
The global Valacyclovir API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-18
Pages: 126
USD 2900.00 (Single User License)
Global Valacyclovir API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Valacyclovir API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-09
Pages: 78
USD 4250.00 (Single User License)
Global Valacyclovir API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Valacyclovir API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-09
Pages: 132
USD 4900.00 (Single User License)
Valacyclovir API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Valacyclovir API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 96
USD 3950.00 (Single User License)
Global Valacyclovir API Market Research Report 2025
The global market for Valacyclovir API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-16
Pages: 92
USD 2900.00 (Single User License)
Global Valacyclovir API Market Research Report 2024
Valaciclovir(CAS：124832-26-4), also spelled valacyclovir, is an antiviral medication used to treat outbreaks of herpes simplex or herpes zoster (shingles).
Published: 2024-02-07
Pages: 102
USD 2900.00 (Single User License)